SCHEMBL15712028

SCHEMBL15712028

c1ccc(-c2cccc3cc[nH]c23)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.50
▸ KDM4E B2RXH2 5/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ TP53 P04637 4/20 0.48
▸ LMNA P02545 3/20 0.48
▸ L3MBTL1 Q9Y468 3/20 0.48
▸ CCR1 P32246 2/20 0.48
▸ CCR5 P51681 2/20 0.48
▸ CCR8 P51685 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ ALOX15 P16050 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ ALPL P05186 1/20 0.48
▸ HSP90AA1 P07900 1/20 0.48
▸ ALPI P09923 1/20 0.48
▸ ALPG P10696 1/20 0.48
▸ CYP1A2 P05177 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ METAP1 P53582 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31688976 0.81 AXL (0.47) AXLNUDT1AHRRENGRM5
SCHEMBL17123043 0.80 MMP2 (0.46) KDM4ESMN1; SMN2TP53LMNACCR1
SCHEMBL30008044 0.80 PRKCI (0.45) PRKCIKDM4ESMN1; SMN2TP53LMNA
SCHEMBL31492457 0.78 AHR (0.60) AHRRENKEAP1
SCHEMBL30741488 0.77 AHR (0.43) AXLNUDT1AHRRENKEAP1
SCHEMBL26260016 0.75 KDM4E (0.58) KDM4ESMN1; SMN2TP53LMNAL3MBTL1
SCHEMBL23098933 0.75 PRKCI (0.46) PRKCIKDM4ESMN1; SMN2TP53LMNA
SCHEMBL31319703 0.75 CCR1 (0.46) PRKCIKDM4ESMN1; SMN2TP53LMNA
Quinoline SCHEMBL27719790 0.74 ALDH1A1 (0.50) POLBAXLNUDT1AHRNPC1
SCHEMBL27924279 0.74 KDM4E (0.65) PRKCIKDM4ESMN1; SMN2TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 — — US disclosed
CN-114867727-A TAU protein targeting compounds and related methods of use 阿尔维纳斯运营股份有限公司 2022-08-05 — — CN disclosed
EP-3621971-B1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-06-23 — — EP disclosed
US-20210079024-A1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-03-18 — — US disclosed
US-20150280147-A1 AROMATIC AZA-BICYCLIC COMPOUNDS CONTAINING CU, AG, AU, ZN, AL FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-10-01 — — US disclosed
US-20150280147-A1 AROMATIC AZA-BICYCLIC COMPOUNDS CONTAINING CU, AG, AU, ZN, AL FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-10-01 — — US disclosed
WO-2014067598-A1 AROMATIC AZA-BICYCLIC COMPOUNDS COMPRISING CU, AG, AU, ZN, AL FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2014-05-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210079024-A1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES CYP1B1, ECI1, FIS1 PRKCI 3354/4885KDM4E 3933/4885SMN1; SMN2 4190/4885
US-20150280147-A1 AROMATIC AZA-BICYCLIC COMPOUNDS CONTAINING CU, AG, AU, ZN, AL FOR USE IN ELECTROLUMINESCENT DEVICES AOC2, AOC1, AOC3 PRKCI 4531/4885KDM4E 1180/4885SMN1; SMN2 3932/4885
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices CYP1B1, ECI1, FIS1 PRKCI 3354/4885KDM4E 3933/4885SMN1; SMN2 4190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback